Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHPA board

This article was originally published in The Tan Sheet

Executive Summary

Perrigo Consumer Healthcare Executive VP & General Manager John Hendrickson has been elected chair of the Consumer Healthcare Products Association by the group's Board of Directors, CHPA announces March 17 during its annual meeting in Aventura, Fla. The group announced Hendrickson as chair-elect in November (1"The Tan Sheet" Nov. 28, 2005, In Brief). Hendrickson succeeds Timothy Hayes of Bayer Healthcare, who will now serve as immediate past chair. In addition, the association, which was founded in 1881, is celebrating its 125th anniversary by unveiling a new, more "modern" logo, President Linda Suydam said...

You may also be interested in...



Electronic Filing Packs Bigger Charge For Supplement AERs Than 3500A Changes

FDA proposes modifications to form 3500A “to enhance the clarity and utility of the information collected,” but the form continues to be more conducive for compiling information on adverse event reported for OTC and Rx drugs than for supplement products.

Electronic Filing Packs Bigger Charge For Supplement AERs Than 3500A Changes

FDA proposes modifications to form 3500A “to enhance the clarity and utility of the information collected,” but the form continues to be more conducive for compiling information on adverse event reported for OTC and Rx drugs than for supplement products.

Supplement GMP Inspections Reveal Adverse Event Reports, Prompting Warning Letters

About 13% of the 156 warning letters FDA sent to dietary supplement firms from 2011 through June 2014 cited firms for failing to report serious adverse events or for not providing on product labels a domestic address or phone number at which to receive AERs. The citation total has climbed steadily from 2011.

Related Content

Topics

UsernamePublicRestriction

Register

PS099192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel